Caitlin Maikawa

Assistant Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Caitlin Maikawa is an Assistant Professor at the University of Toronto, Canada. Her research focuses on the development of innovative biopharmaceutical formulations and hydrogel systems for diabetes management and cancer studies. Recent articles include investigations into hydrogel coatings for implantable devices and the delivery of antibodies for SARS-CoV-2, reflecting her expertise in biocompatibility and drug delivery technologies.

Articles (10)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Anton Allen Abbotsford Autzen

Technical University of Denmark

DENMARK

View details

Eric Appel

Assistant Professor

Stanford University

UNITED STATES

View details

Ryanne Brown

Stanford University School of Medicine

UNITED STATES

View details

Eric Y. Ma

UNITED STATES

View details

Matthew Webber

Assistant Professor

University of Notre Dame

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Caitlin Maikawa

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Polyacrylamide‐based hydrogel coatings improve biocompatibility of implanted pump devices

Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot

Controlling properties of thermogels by tuning critical solution behaviour of ternary copolymers

A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals

Consistent tumorigenesis with self-assembled hydrogels enables high-powered murine cancer studies

Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.

Engineering biopharmaceutical formulations to improve diabetes management

A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs

An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients

Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues

Collaborators (5)

Anton Allen Abbotsford Autzen

Eric Appel

Ryanne Brown

Eric Y. Ma

Matthew Webber

Make your next move.